190 Results

People

  1. Saltz
    Saltz
  2. Kelsen
    Kelsen
  3. Bajorin
    Bajorin
  4. O'Reilly
    O'Reilly
  5. Abrey
    Abrey
  6. Marks
    Marks
  7. Aghajanian
    Aghajanian
  8. Ilson
    Ilson
  9. De Angelis
    De Angelis
  10. Kelly
    Kelly

Groups

  1. Department of Medicine (143)
  2. Solid Tumor Oncology Division (115)
  3. Gastrointestinal Oncology Service (39)
  4. Epidemiology and Biostatistics (31)
  5. Biostatistics Service (29)
  6. Center for Pancreatic Cancer Research (29)
  7. Hematologic Malignancies, Division of (29)
  8. Survivorship Research (27)
  9. Genitourinary Oncology Service (25)
  10. Surgery (25)
  1. "dehydration"
Formats
  1. Journal Article (185)
  2. Review (2)
  3. Book Section (1)
  4. Conference Paper (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (143)
  2. Solid Tumor Oncology Division (115)
  3. Gastrointestinal Oncology Service (39)
  4. Epidemiology and Biostatistics (31)
  5. Biostatistics Service (29)
  6. Center for Pancreatic Cancer Research (29)

More Groups

People
  1. Leonard Saltz (12)
  2. David Kelsen (10)
  3. Dean Bajorin (9)
  4. Eileen O'Reilly (9)
  5. Lauren Abrey (8)
  6. Paul Marks (8)

More People

Years
  1. 2025 (1)
  2. 2024 (11)
  3. 2023 (7)
  4. 2022 (2)
  5. 2021 (6)
  6. 2020 (11)

More Years

Publications
  1. Cancer (17)
  2. Journal of Clinical Oncology (16)
  3. Lancet Oncology (14)
  4. Gynecologic Oncology (10)
  5. Investigational New Drugs (10)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (31)
  2. Springer (21)
  3. Wiley Blackwell (20)
  4. American Society of Clinical Oncology (16)
  5. Elsevier Science, Inc. (16)
  6. Oxford University Press (16)

More Publishers

Results (190)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study
    Journal Article

    Campos, S. M.; Brady, W. E.; Moxley, K. M.; O'Cearbhaill, R. E.; Lee, P. S.; Disilvestro, P. A.; Rotmensch, J.; Rose, P. G.; Thaker, P. H.; O'Malley, D. M.; more...
    Gynecologic Oncology (2014)

    Fulltext@MSK | Save
  • Ceritinib in ALK-rearranged non-small-cell lung cancer
    Journal Article

    Shaw, A. T.; Kim, D. W.; Mehra, R.; Tan, D. S. W.; Felip, E.; Chow, L. Q. M.; Camidge, D. R.; Vansteenkiste, J.; Sharma, S.; De Pas, T.; more...
    New England Journal of Medicine (2014)

    Fulltext@MSK | Save
  • Phase II trial of patupilone in patients with brain metastases from breast cancer
    Journal Article

    Peereboom, D. M.; Murphy, C.; Ahluwalia, M. S.; Conlin, A.; Eichler, A.; Van Poznak, C.; Baar, J.; Elson, P.; Seidman, A. D.
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Journal Article

    Fury, M. G.; Sherman, E. J.; Rao, S. S.; Wolden, S.; Smith-Marrone, S.; Mueller, B.; Ng, K. K.; Dutta, P. R.; Gelblum, D. Y.; Lee, J. L.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
    Journal Article

    Rathkopf, D. E.; Picus, J.; Hussain, A.; Ellard, S.; Chi, K. N.; Nydam, T.; Allen-Freda, E.; Mishra, K. K.; Porro, M. G.; Scher, H. I.; more...
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • Phase II study of everolimus in metastatic urothelial cancer
    Journal Article

    Milowsky, M. I.; Iyer, G.; Regazzi, A. M.; Al-Ahmadie, H.; Gerst, S. R.; Ostrovnaya, I.; Gellert, L. L.; Kaplan, R.; Garcia-Grossman, I. R.; Pendse, D.; more...
    BJU International (2013)

    Fulltext@MSK | Save
  • A phase I trial of the kinesin spindle protein (Eg5) inhibitor AZD4877 in patients with solid and lymphoid malignancies
    Journal Article

    Gerecitano, J. F.; Stephenson, J. J.; Lewis, N. L.; Osmukhina, A.; Li, J.; Wu, K.; You, Z.; Huszar, D.; Skolnik, J. M.; Schwartz, G. K.
    Investigational New Drugs (2013)

    Fulltext@MSK | Save
  • Phase i study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors
    Journal Article

    Schwartz, G. K.; Carvajal, R. D.; Midgley, R.; Rodig, S. J.; Stockman, P. K.; Ataman, O.; Wilson, D.; Das, S.; Shapiro, G. I.
    Investigational New Drugs (2013)

    Fulltext@MSK | Save
  • Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence companion study 60104 for CALGB 49907)
    Journal Article

    Ruddy, K. J.; Pitcher, B. N.; Archer, L. E.; Cohen, H. J.; Winer, E. P.; Hudis, C. A.; Muss, H. B.; Partridge, A. H.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401
    Journal Article

    Kelly, W. K.; Halabi, S.; Carducci, M.; George, D.; Mahoney, J. F.; Stadler, W. M.; Morris, M.; Kantoff, P.; Monk, J. P.; Kaplan, E.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save